Godfrey Pimundu

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation

Claire D. Bourke, Ethan Gough, Godfrey Pimundu et al. · Science Translational Medicine · 2019 · 91 citations · Full text

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

Nicholas I. Paton, Cissy Kityo, Immaculate Nankya et al. · The Lancet HIV · 2017 · 79 citations · Full text

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

James Hakim, Cissy Kityo, Anne Hoppé et al. · The Lancet Infectious Diseases · 2017 · 41 citations · Full text

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy

Andrew J. Prendergast, Alexander J. Szubert, Chipo Berejena et al. · The Journal of Infectious Diseases · 2016 · 21 citations · Full text

The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa

Andrew J. Prendergast, Alexander J. Szubert, Godfrey Pimundu et al. · AIDS · 2021 · 12 citations · Full text